This lawsuit looks pretty serious.. In a bold gamble,

New Post Public Reply Private Reply Replies (0) Message Board
thora001
This lawsuit looks pretty serious..

In a bold gamble, Kasowitz, Benson, Torres & Friedman has blown the whistle on four of the country’s largest chemical companies, assuming the role of both plaintiff and counsel in a $90 billion qui tam case.
Citing documents discovered in a prior case, the 350-lawyer New York-based litigation powerhouse says The Dow Chemical Co., Bayer MaterialScience, BASF Corp. and Huntsman International failed to inform the U.S. Environmental Protection Agency of serious health injuries caused by a common chemical.
As the relator, the firm if successful could (in theory) reap up to 30 percent of the damages, or $27 billion. But there are some very steep hurdles to overcome first.
The suit arose from the firm’s prior work representing 1,500 coal miners in a product liability suit in Alabama. During the course of discovery in that case, Bice, et al. v. Micon, Inc., et al., Kasowitz lawyers found a series of reports by an industry trade group that looked a lot like a smoking gun. Even better, the documents weren’t subject to protective orders.
According to the complaint, the reports show that the chemical companies failed to inform the EPA that merely touching or inhaling a minute amount of isocyanate—a ubiquitous chemical used in everything from mattresses to car dashboards to paint—can cause permanent pulmonary injury in humans.
The miners’ suit settled on confidential terms in 2010—and the Kasowitz lawyers saw an opportunity to bring a massive False Claims Act suit. Not on behalf of the miners, who all signed releases and didn’t have knowledge of the reports anyway, but with the firm itself acting as the plaintiff—a rare but not unheard-of step.
“The defendants’ cover-up implicates major human health concerns,” said Kasowitz partner Andrew Davenport, who is taking the lead on the case along with partners Daniel Benson and Lyn Agre. “The whistleblower law allows us to assist the federal government in holding these companies responsible for their actions while we also alert regulators and the public to the serious undisclosed hazards of these chemicals.”
The firm filed a 394-page complaint in U.S. District Court for the Northern District of California last year. It was unsealed in August, after the federal government declined to intervene.
According to a report by the U.S. Chamber Institute for Legal Reform, the Justice Department intervenes in about 23 percent of qui tam cases. When that happens, the feds win a settlement or judgment 95 percent of the time. But when they don’t step in, the plaintiffs prevail only 6 percent of the time.
It’s a stat that’s apparently not lost on the chemical companies, which were served with the suit last week.
“The U.S. government declined to intervene, and the law firm alone is now proceeding with the lawsuit,” a spokeswoman for Covestro LLC (formerly Bayer MaterialScience), said in an email. “Covestro LLC strongly disputes the allegations of the lawsuit, considers them to be without merit, and intends to vigorously defend itself.”
Likewise, a spokeswoman for Dow called the complaint “meritless. Dow has complied with all the federal laws and requirements referenced in the complaint,” said Rachelle Schikorra, associate director of public affairs. “It is noteworthy that the law firm provided these allegations to the United States Department of Justice, which declined to intervene or take any action in support of the lawsuit.”
“Moreover,” she added, “the False Claims Act does not allow a claim for unassessed civil penalties.”
That question—whether a company can be obliged to pay a fine that hasn’t yet been levied—could stall the suit.
Another central issue in the suit is what exactly the chemical companies were obligated to disclose regarding the safety risks of isocyanate, given that federal guidelines require people who work with isocyanates to wear protective gear.
According to the complaint, though, the chemical companies have concealed just how bad isocyanates really are. As little as one drop on the skin could cause permanent respiratory injury in humans, Kasowitz alleges.

Hybrid Coating Technologies, Inc. (HCTI) Stock Research Links

HCTI Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Fractional CIOs Bring Order to Growing Technology Chaos

Updated Category News Views 41

A company can outgrow its technology habits long before anyone notices the smoke. One day the owner is approving another software subscription, the office manager is chasing an internet provider, and the tech person is putting out password fires. None of that looks dramatic in isolation. Together, it is a business operating without a map. That is the useful point in the...

Continue Reading
Mars Sets $2 Billion Debt Tender With Kellanova Notes

Updated Category News Views 124

A two-billion-dollar vacuum cleaner just switched on inside Mars’s debt stack, and the timing is anything but casual. On November 20, Mars fixed the pricing for cash tender offers spanning selected Mars and Kellanova senior notes, with holders facing a 5:00 p.m. New York deadline that same day. This is the kind of filing that looks like bond-market plumbing until you...

Continue Reading
Employer Ghosting Is a Quiet Talent-Cost Problem Today

Updated Category News Views 97

Silence is cheap right up until a company needs talent again. Then the unanswered email, abandoned interview loop, or vanished promise of next steps comes back with a price tag—maybe not neatly labeled in a quarterly filing, but real all the same. LiveCareer’s April 14, 2026 survey of 1,008 employed U.S. adults lands on an uncomfortable point: candidates remember...

Continue Reading
Highmark’s 2026 Rebound Has a Few Asterisks Attached

Updated Category News Views 74

The Headline Needs a Pencil, Not a Highlighter A $1.9 billion net-income figure can look downright thunderous until you separate the cash-generating engine from the accounting cargo strapped to it. Highmark Health reported $26.5 billion in revenue and $741 million in operating income for the nine months ended Sept. 30, 2026. Those are materially better numbers than the...

Continue Reading
California Initiative Puts Missed Diagnoses in Focus

Updated Category News Views 73

When Reassurance Turns Into a Risk A clean scan can become a dangerous lullaby when symptoms refuse to leave. That is the hard, unsettling territory behind Hodes Milman’s new Missed Diagnosis Project: California, launched November 20, 2026. The statewide effort focuses on breast cancer diagnostic failures: scans read as benign when more scrutiny was warranted, referrals...

Continue Reading
Fluence Investors Face a November 27 Litigation Clock

Updated Category News Views 72

Six calendar squares are all that separate eligible Fluence investors from the November 27, 2026 lead-plaintiff deadline. That is not much time to locate trade confirmations, calculate losses, and decide whether taking a larger role in a securities case makes sense. The lawsuit is not a verdict, and anybody pretending otherwise is selling smoke. But the underlying...

Continue Reading
University of Phoenix Poll Gets a Useful Reality Check

Updated Category News Views 117

Good Numbers, With the Usual Fine Print Employer approval is the kind of evidence career-focused schools desperately need, and University of Phoenix just put up a pretty loud batch of it. Among managers who directly supervise its graduates, 94% said the university understands employer needs, while 92% said its programs align with workforce demands. Those are stout...

Continue Reading
Maryland Handgun Ban Suit Puts Ruger in Legal Crossfire

Updated Category News Views 111

A January Deadline With Real Commercial Teeth Maryland has turned a trigger-design dispute into a fresh legal and retail headache, and the clock is not polite about it. The National Shooting Sports Foundation filed suit against the state over S.B. 334, which is scheduled to take effect Jan. 1, 2027. The law bars sales of certain pistols with cruciform trigger bars,...

Continue Reading
Chord's $550 Million Exit Tightens Its Basin Focus

Updated Category News Views 83

One map pin just disappeared from Chord Energy’s corporate wall, and that matters more than the usual deal-closing confetti. Chord has completed the sale of its entire non-operated Marcellus position to POSCO International for $550 million in gross consideration. For shareholders in NASDAQ:CHRD, this is not a flashy new drilling story. It is a cleanup job, and sometimes...

Continue Reading
BON’s Oat Lab Bet Puts Scale and Standards in Focus

Updated Category News Views 32

Oats Meet the Industrialization Problem Oats rarely make a small-cap story more interesting, yet this one has a real business nerve running through it. Bon Natural Life has teamed with China Oat Group to establish a joint laboratory aimed at biomanufacturing high-value, oat-derived natural ingredients. The headline is not simply another research collaboration. The stated...

Continue Reading

Top 5 Most Recently Viewed Articles

Fluor Corporation Investors Alert: Join the Class Action Now

Updated Category News Views 153

Fluor Corporation Class Action Overview The Portnoy Law Firm has issued an important announcement regarding Fluor Corporation's recent class action lawsuit. Investors who purchased securities of Fluor during a specified period are encouraged to participate. Details of the Class Action This class action is targeting investors who acquired Fluor Corporation shares from...

Continue Reading
Maravai LifeSciences Investors: Are You Affected by Recent Issues?

Updated Category News Views 141

Maravai LifeSciences Holdings, Inc. Overview Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) has quickly become a pivotal player in the biopharmaceutical sector. Their innovative approach and dedication to improving scientific methods have attracted attention from investors and stakeholders alike. However, recent events have thrown some uncertainty into the landscape...

Continue Reading
Gesa Credit Union Acquires Willamette Valley Bank

Updated Category News Views 73

Community Banking Shake-Up in the Pacific Northwest Ah, mergers and acquisitions—they’re like spices in the economic salsa. Today's special? Gesa Credit Union, one of Washington’s powerhouses, deciding to acquire Willamette Valley Bank. Nothing gets the business blood pumping like a good ol' fashioned acquisition. The Financial Backdrop This deal isn't some casual...

Continue Reading
Market Uncertainty Eases as Economic Data Floods In

Updated Category News Views 181

Market Uncertainty Eases as Economic Data Floods In The US government shutdown has come to an end. However, as soon as the funding bill was signed, the markets shifted their focus toward the substantial economic data that has been delayed for over six weeks. This hiatus lasted for forty-three days without any federal reporting, resulting in a significant gap in available...

Continue Reading
AIM Congress 2026: Shaping Future Investment Pathways

Updated Category News Views 510

Exciting News About AIM Congress 2026 The Organizing Committee of AIM Congress, the foremost investment platform globally, has announced the launch of its 15th edition, centered around the compelling theme: Reshaping Global Prosperity: Unlocking New Investment Pathways Towards a Sustainable and Inclusive Future. This prestigious event is set to take place in April 2026 at...

Continue Reading